4:35 PM
 | 
Aug 09, 2013
 |  BC Extra  |  Financial News

ContraVir seeking public listing

The ContraVir Pharmaceuticals Inc. subsidiary of gastrointestinal company Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) filed a Form 10 with the SEC to become a publicly reporting company listed on...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >